DK0674634T3 - Fremgangsmåde til fremstilling af substituerede 1,3-oxathiolaner med antivirale egenskaber - Google Patents
Fremgangsmåde til fremstilling af substituerede 1,3-oxathiolaner med antivirale egenskaberInfo
- Publication number
- DK0674634T3 DK0674634T3 DK93900063T DK93900063T DK0674634T3 DK 0674634 T3 DK0674634 T3 DK 0674634T3 DK 93900063 T DK93900063 T DK 93900063T DK 93900063 T DK93900063 T DK 93900063T DK 0674634 T3 DK0674634 T3 DK 0674634T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxathiolanes
- antiviral properties
- preparing substituted
- compounds
- preparing
- Prior art date
Links
- WJJSZTJGFCFNKI-UHFFFAOYSA-N 1,3-oxathiolane Chemical class C1CSCO1 WJJSZTJGFCFNKI-UHFFFAOYSA-N 0.000 title 1
- 230000000840 anti-viral effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/308,101 US5047407A (en) | 1989-02-08 | 1989-02-08 | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US56416090A | 1990-08-07 | 1990-08-07 | |
| PCT/CA1992/000557 WO1994014802A1 (fr) | 1989-02-08 | 1992-12-21 | Procedes de preparation de 1,3-oxathiolanes substituees aux proprietes antivirales |
| CA002152269A CA2152269C (fr) | 1989-02-08 | 1992-12-21 | Methode de preparation de derives de substitution de 1,3-oxathiolanes aux proprietes antivirales |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0674634T3 true DK0674634T3 (da) | 2003-08-04 |
Family
ID=27170036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93900063T DK0674634T3 (da) | 1989-02-08 | 1992-12-21 | Fremgangsmåde til fremstilling af substituerede 1,3-oxathiolaner med antivirale egenskaber |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0674634B1 (fr) |
| JP (1) | JP3160291B2 (fr) |
| AT (1) | ATE237613T1 (fr) |
| AU (1) | AU3154993A (fr) |
| CA (1) | CA2152269C (fr) |
| DE (1) | DE69233014T2 (fr) |
| DK (1) | DK0674634T3 (fr) |
| ES (1) | ES2196004T3 (fr) |
| HU (1) | HU226137B1 (fr) |
| PT (1) | PT674634E (fr) |
| WO (1) | WO1994014802A1 (fr) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5684164A (en) * | 1988-04-11 | 1997-11-04 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
| US5827727A (en) * | 1990-02-01 | 1998-10-27 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
| US5914331A (en) * | 1990-02-01 | 1999-06-22 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
| GB9116601D0 (en) * | 1991-08-01 | 1991-09-18 | Iaf Biochem Int | 1,3-oxathiolane nucleoside analogues |
| US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
| CA2171550C (fr) | 1993-09-10 | 2008-08-26 | Raymond F. Schinazi | Nucleosides avec activite virale anti-hepatite b |
| US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
| IL113432A (en) * | 1994-04-23 | 2000-11-21 | Glaxo Group Ltd | Process for the diastereoselective synthesis of nucleoside analogues |
| US5703058A (en) | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
| US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
| US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
| ATE346651T1 (de) | 1995-06-07 | 2006-12-15 | Univ Emory | Nucleoside mit anti-hepatitis b virus wirksamkeit |
| US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
| IT1290447B1 (it) | 1997-03-28 | 1998-12-03 | Zambon Spa | Derivati 1,3-ossatiolanici ad attivita' antivirale |
| JP2001518899A (ja) | 1997-04-07 | 2001-10-16 | トライアングル ファーマシューティカルズ，インコーポレイティド | 他の抗ウイルス剤との組合せにおけるｍｋｃ−４４２の使用 |
| OA11741A (en) | 1998-12-23 | 2005-05-13 | Iaf Biochem Int | Antiviral nucleoside analogues. |
| CN1620295A (zh) * | 2001-12-14 | 2005-05-25 | 法玛塞特有限公司 | 制备用于合成抗病毒核苷的中间体 |
| DE10238722A1 (de) | 2002-08-23 | 2004-03-11 | Bayer Ag | Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse |
| DE10238724A1 (de) | 2002-08-23 | 2004-03-04 | Bayer Ag | Alkyl-substituierte Pyrazolpyrimidine |
| AU2008331166B2 (en) | 2007-11-29 | 2013-10-10 | Ranbaxy Laboratories Limited | Process for the preparation of substituted 1,3-oxathiolanes |
| PE20091211A1 (es) | 2007-11-30 | 2009-09-14 | Boehringer Ingelheim Int | Derivados de pirazolopirimidina como moduladores de pde9a |
| UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
| CA2736304A1 (fr) | 2008-09-08 | 2010-03-11 | Boehringer Ingelheim International Gmbh | Pyrazolopyrimidines et leur utilisation pour le traitement de troubles du snc |
| GEP20146098B (en) | 2009-03-31 | 2014-05-27 | Boehringer Ingelheim Int | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their usage as pde9a modulators |
| MX344770B (es) | 2010-08-12 | 2017-01-06 | Boehringer Ingelheim Int Gmbh * | Derivados de 6-cicloalquil-1,5-dihidro-pirazolo (3,4-d) pirimidin-4-onas y su uso como inhibidores de pde9a. |
| US8809345B2 (en) | 2011-02-15 | 2014-08-19 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
| CN104059057A (zh) * | 2014-01-03 | 2014-09-24 | 石家庄龙泽制药有限公司 | 拉米夫定杂质3-tu的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| AU8864191A (en) * | 1990-11-13 | 1992-06-11 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
| WO1992010496A1 (fr) * | 1990-12-05 | 1992-06-25 | University Of Georgia Research Foundation, Inc. | NUCLEOSIDES DE β-L-(-)-1,3-OXATHIOLANE ENANTIOMERIQUEMENT PURS |
| NZ250842A (en) * | 1991-02-22 | 1996-03-26 | Univ Emory | Resolution of a racemic mixture of nucleoside enantiomers such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (ftc) |
| ES2286072T3 (es) * | 1991-03-06 | 2007-12-01 | Emory University | Sales de amidas de (-)cis 5 fluoro-2'-dedoxi-3'-tiacitidina utiles para el tratamiento de la hepatitis b. |
| WO1992018517A1 (fr) * | 1991-04-17 | 1992-10-29 | Yale University | Procede de traitement ou de prevention du virus de l'hepatite b |
| ZA923640B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
-
1992
- 1992-12-21 EP EP93900063A patent/EP0674634B1/fr not_active Expired - Lifetime
- 1992-12-21 PT PT93900063T patent/PT674634E/pt unknown
- 1992-12-21 JP JP51462194A patent/JP3160291B2/ja not_active Expired - Fee Related
- 1992-12-21 DE DE69233014T patent/DE69233014T2/de not_active Expired - Fee Related
- 1992-12-21 WO PCT/CA1992/000557 patent/WO1994014802A1/fr not_active Ceased
- 1992-12-21 HU HU9501825A patent/HU226137B1/hu not_active IP Right Cessation
- 1992-12-21 DK DK93900063T patent/DK0674634T3/da active
- 1992-12-21 AT AT93900063T patent/ATE237613T1/de not_active IP Right Cessation
- 1992-12-21 AU AU31549/93A patent/AU3154993A/en not_active Abandoned
- 1992-12-21 CA CA002152269A patent/CA2152269C/fr not_active Expired - Fee Related
- 1992-12-21 ES ES93900063T patent/ES2196004T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69233014D1 (de) | 2003-05-22 |
| HU9501825D0 (en) | 1995-08-28 |
| ATE237613T1 (de) | 2003-05-15 |
| WO1994014802A1 (fr) | 1994-07-07 |
| ES2196004T3 (es) | 2003-12-16 |
| DE69233014T2 (de) | 2004-01-08 |
| JPH08504212A (ja) | 1996-05-07 |
| EP0674634A1 (fr) | 1995-10-04 |
| AU3154993A (en) | 1994-07-19 |
| CA2152269A1 (fr) | 1994-07-07 |
| HUT73655A (en) | 1996-09-30 |
| PT674634E (pt) | 2003-09-30 |
| CA2152269C (fr) | 1999-09-21 |
| EP0674634B1 (fr) | 2003-04-16 |
| HU226137B1 (en) | 2008-05-28 |
| JP3160291B2 (ja) | 2001-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0674634T3 (da) | Fremgangsmåde til fremstilling af substituerede 1,3-oxathiolaner med antivirale egenskaber | |
| EP0382526A3 (fr) | 1,3-oxathiolanes substitués doués de propriétés antivirales | |
| DK0560794T3 (da) | Substituerede 1,3-oxathiolaner med antivirale egenskaber | |
| ATE134644T1 (de) | Weitere antivirale pyrimidin-nukleosiden | |
| NO179906C (no) | Fremgangsmåte for fremstilling av hydroksymetyl(metylencyklopentyl) puriner og -pyrimidiner | |
| MY105523A (en) | Substituted-1,3-oxathiolanes with antiviral properties. | |
| MD950086A (ro) | Utilizare a analogilor nucleozidici ai 1,3-oxatiolanei in tratamentul hepatitei B Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis B | |
| ES2091212T3 (es) | Compuestos de xantina. | |
| DK0400472T3 (da) | Fremgangsmåde til fremstilling af polyethylenglycolderivater og modificeret protein | |
| PT89349A (pt) | Processo para a preparacao de purinil e pirimidinil ciclobutanos | |
| FI98729B (fi) | Menetelmä farmaseuttisesti vaikuttavan puriinijohdannaisen valmistamiseksi | |
| DE69108014D1 (de) | Verfahren zur herstellung von nucleosiden und ihre analogen. | |
| NO20084343L (no) | Fremgangsmate for fremstilling av 6-(4-fenylbutoksy)heksylaminderivater | |
| FI891004A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi | |
| DK0428313T3 (da) | Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser | |
| HUT54153A (en) | Process for producing purinyl- and pyrimidinyltetrahydrofuran derivatives and pharmaceutical compositions comprising same | |
| DK0468445T3 (da) | Fremgangsmåde til fremstilling af 6-(substitueret aminopropionyl)-derivater af forskolin | |
| FI910816L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 3H-6H-1,4,5a,8a,-tetra-atsa-asenaftyleeni-3,5(4H)-dionijohdannaisten valmistamiseksi |